WallStreetZenWallStreetZen

NASDAQ: CUE
Cue Biopharma Inc Stock Ownership - Who owns Cue Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cue Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sumita RayCLO2026-08-136,442$30.35
$195.51kSell
Sumita RayCLO2026-08-134$31.13
$124.52Sell
Shaolee LinCEO2026-08-135,423$27.19
$147.45kSell
Shaolee LinCEO2026-08-132,375$28.11
$66.76kSell
Shaolee LinCEO2026-08-1310,460$29.48
$308.36kSell
Michael Vincent MeluzioVP2026-08-131,519$29.37
$44.61kSell
Michael Vincent MeluzioVP2026-08-134,106$30.35
$124.62kSell
Michael Vincent MeluzioVP2026-08-133$31.13
$93.39Sell
Sumita RayCLO2026-08-132,383$29.37
$69.99kSell
Shaolee LinCEO2026-08-1234,225$26.99
$923.73kSell

1 of 2

CUE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CUE insiders and whales buy or sell their stock.

CUE Shareholders

What type of owners hold Cue Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cameron Gray17.66%1,283,249$30.77MInsider
Aaron Gl Fletcher15.33%1,113,867$26.71MInsider
Michael J. Fox15.14%1,100,000$26.38MInsider
Christopher A. Marlett10.58%768,503$18.43MInsider
Shaolee Lin9.72%705,995$16.93MInsider
Rodolfo Chaparro6.13%445,000$10.67MInsider
Ronald D. Seidel Iii6.13%445,000$10.67MInsider
Daniel R. Passeri2.27%164,578$3.95MInsider
Anish Suri1.87%135,638$3.25MInsider
Sumita Ray1.63%118,545$2.84MInsider

1 of 3

CUE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CUE0.02%92.06%Net BuyingNet Selling
CNTN0.03%7.04%Net SellingNet Selling
INDP0.00%74.86%Net Buying
MDWD0.05%0.20%Net BuyingNet Buying
CRBU0.05%8.03%Net Selling
View Top Biotech Stocks

Cue Biopharma Stock Ownership FAQ

Who owns Cue Biopharma?

Cue Biopharma (NASDAQ: CUE) is owned by 0.02% institutional shareholders, 92.06% Cue Biopharma insiders, and 7.92% retail investors. Cameron Gray is the largest individual Cue Biopharma shareholder, owning 1.28M shares representing 17.66% of the company. Cameron Gray's Cue Biopharma shares are currently valued at $30.77M.

If you're new to stock investing, here's how to buy Cue Biopharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.